Michael L. Ryan of Bristol Myers Squibb Elected Board Chair of National Pharmaceutical Council
Today the National Pharmaceutical Council (NPC) announced that Michael L. Ryan, PharmD, Senior Vice President, Worldwide Value, Access, Pricing and [...]
Benefits–Not Just Costs–of Medicines Must Be a Part of Discussion
According to Dr. Robert W. Dubois, Interim President and CEO of NPC, in the context of healthcare costs, the amount [...]
With Dr. Robert Dubois at the Helm, the National Pharmaceutical Council (NPC) Solidifies Commitment to High-Quality Patient-Centered Research and Evidence-based Dialogue
Dr. Robert Dubois, the newly appointed interim president and CEO of NPC, outlined his vision for the organization during his [...]
Robert Dubois, MD, PhD, Steps in as Interim President and CEO of The National Pharmaceutical Council (NPC).
Today the National Pharmaceutical Council (NPC) announced the appointment of Robert Dubois, MD, PhD, as interim president and CEO, replacing [...]
Innovation and Value Initiative’s (IVI) Jennifer Bright on Value Assessment and Transparency
Jennifer Bright is Executive Director of the Innovation and Value Initiative (IVI), a non-profit organization whose mission is to to [...]
Association for Accessible Medicines (AAM) Names Health Care Advocate Dan Leonard President and CEO
Dan Leonard was appointed President and Chief Executive Officer of The Association for Accessible Medicines (AAM) today by the association’s [...]
Proposed change to CMS Rules Aim Will Expand Access to High-cost Therapies for Medicaid Recipients
The Medicaid Best Price rule requires drug manufacturers to give Medicaid the best price on all purchases. However, the rule [...]
NPC Comments on NQF’s Draft Report on Patient-reported Outcomes (PROs)
The National Quality Forum (NQF) released a draft report on June 1, 2020 entitled "Patient-Reported Outcomes: Best Practices on Selection [...]
Report Spotlights NPC’s Webinar on COVID-19 Prices
A recent report by The Pink Sheet spotlights the National Pharmaceutical Council's (NPC) recent meeting on COVID-19 drug prices. The [...]
NPC Spotlights New NPC/Duke-Margolis Health Policy Fellow Salama Freed
A recent National Pharmaceutical Council blog post spotlights Salama Freed, the new NPC/Duke-Margolis Postdoctoral Health Policy fellow. Freed says she [...]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains [...]
NPC Blog Post Reflects on AMCP’s Format
The National Pharmaceutical Council (NPC) in a recent blog post reflects on the Academy of Managed Care Pharmacy's (AMCP) Format [...]
Dubois: It’s Time to Talk COVID-19 Prices
In a race to develop a vaccine for COVID-19, the biopharmaceutical industry has worked at "unheard-of speed," National Pharmaceutical Council [...]
Research Considers Valuation of Indirect Benefits
The National Pharmaceutical Council (NPC) and RTI Health Solutions in research published earlier this year found the inclusion of indirect [...]
Experts: Including Productivity in Value Assessment Frameworks Can Make Difference
The National Pharmaceutical Council (NPC) in a recent study published in JAMA suggests including productivity in value assessments can have [...]
Panel Discusses How Pandemic Might Impact Value of Innovation
A panel discussion during the eyeforpharma Virtual Conference discussed how the pandemic might impact the value of innovation, productivity and [...]
NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to [...]
NPC Webinar to Spotlight Evidence-Based Health Coverage
The National Pharmaceutical Council (NPC) is slated to host a webinar noon EST Feb. 13 highlighting evidence-based coverage decisions by [...]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list [...]
SWHR’s Kocsis: Women Matter in Value Assessments
The National Pharmaceutical Council (NPC) recently sat down with the Society for Women's Health Research (SWHR) Vice President of Public [...]
Webinar Spotlights Low-Value Care
A Jan. 15 webinar hosted by the Going Below the Surface Forum, in partnership with AcademyHealth and the National Pharmaceutical [...]
NPC: No ‘Best’ Framework for Value Assessment
The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no [...]
Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint
Swarali Tadwalkar, MPHIntern Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the [...]